Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $170.3M
Liabilities Breakdown FY2018
Total Liabilities: $56.2M
Asset Breakdown
Total Assets: $170.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $18.8M | 11.1% |
| Accounts Receivable | $8.6M | 5.0% |
| Inventory | $17.9M | 10.5% |
| Property, Plant & Equipment | $34.1M | 20.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $90.9M | 53.4% |
Liabilities Breakdown
Total Liabilities: $56.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.7M | 12.0% |
| Long-Term Debt | $14.7M | 26.1% |
| Other Liabilities | $34.8M | 61.9% |